GLPwatch
Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control
NCT00806520 · Completed
Last updated 2026-05-28This clinical trial tests the use of continuous glucose monitoring combined with ambulatory glucose profiles to track blood sugar levels in people with type 2 diabetes.
Status Completed The study has finished.
Type Observational
Participants 16 people
Who can join Ages 18+ · all sexes
Timeline Started 2008-04 · est. completion 2011-08
Where 5 sites · United States
What this study is testing ClinicalTrials.gov NCT00806520 ↗
Description as written by the study sponsor.
Obtain Continuous Glucose Monitoring (CGM) data from individuals taking exenatide LAR, sitagliptin, or pioglitazone. The CGM measurements collected will help determine the characteristics of glucose control prior to treatment and during treatment.
| Sponsor | HealthPartners Institute |
|---|---|
| Conditions studied | Type 2 Diabetes |
| GLP-1 drugs | — |
Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT00806520 ↗